Elizabeth Cermak - May 25, 2023 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
Director
Signature
/s/ Jonathan Foster by Power of Attorney
Stock symbol
MBRX
Transactions as of
May 25, 2023
Transactions value $
$0
Form type
4
Date filed
5/26/2023, 05:16 PM
Previous filing
Jun 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Stock option (right to buy) Award +15K +27.27% 70K May 25, 2023 Common Stock 15K $0.62 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options set forth in this table vest on the earlier of one year from the date of the Company's 2023 annual meeting of stockholders or on the next annual meeting of stockholders, subject to the grantee's continued service on the Company's Board of Directors on such vesting date.
F2 The options were issued in connection with the reporting person's Board of Director service to the Company.